149 related articles for article (PubMed ID: 1968726)
1. Topical levocabastine protects better than sodium cromoglycate and placebo in conjunctival provocation tests.
Rimås M; Kjellman NI; Blychert LO; Björkstén B
Allergy; 1990 Jan; 45(1):18-21. PubMed ID: 1968726
[TBL] [Abstract][Full Text] [Related]
2. Double-blind comparison of levocabastine eye drops with sodium cromoglycate and placebo in the treatment of seasonal allergic conjunctivitis.
Azevedo M; Castel-Branco MG; Oliveira JF; Ramos E; Delgado L; Almeida J
Clin Exp Allergy; 1991 Nov; 21(6):689-94. PubMed ID: 1685691
[TBL] [Abstract][Full Text] [Related]
3. Topical levocabastine versus sodium cromoglycate in allergic conjunctivitis.
Odelram H; Björkstén B; af Klercker T; Rimås M; Kjellman NI; Blychert LO
Allergy; 1989 Aug; 44(6):432-6. PubMed ID: 2572181
[TBL] [Abstract][Full Text] [Related]
4. A comparison of topical levocabastine and sodium cromoglycate in the treatment of pollen-provoked allergic conjunctivitis.
Frostad AB; Olsen AK
Clin Exp Allergy; 1993 May; 23(5):406-9. PubMed ID: 8101467
[TBL] [Abstract][Full Text] [Related]
5. Comparison of effects of topical levocabastine and nedocromil sodium on the early response in a conjunctival provocation test with allergen.
Hammann C; Kämmerer R; Gerber M; Spertini F
J Allergy Clin Immunol; 1996 Dec; 98(6 Pt 1):1045-50. PubMed ID: 8977503
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the efficacy and tolerability of topical levocabastine and sodium cromoglycate in the treatment of seasonal allergic rhinoconjunctivitis in children.
Vermeulen J; Mercer M
Pediatr Allergy Immunol; 1994 Nov; 5(4):209-13. PubMed ID: 7894627
[TBL] [Abstract][Full Text] [Related]
7. Topical levocabastine is more effective than sodium cromoglycate for the prophylaxis and treatment of seasonal allergic conjunctivitis.
Davies BH; Mullins J
Allergy; 1993 Oct; 48(7):519-24. PubMed ID: 7902022
[TBL] [Abstract][Full Text] [Related]
8. Levocabastine versus cromolyn sodium in the treatment of pollen-induced conjunctivitis.
Ciprandi G; Cerqueti PM; Sacca S; Cilli P; Canonica GW
Ann Allergy; 1990 Aug; 65(2):156-8. PubMed ID: 1974402
[TBL] [Abstract][Full Text] [Related]
9. Emedastine ophthalmic solution 0.05% versus levocabastine ophthalmic suspension 0.05% in the treatment of allergic conjunctivitis using the conjunctival allergen challenge model.
Netland PA; Leahy C; Krenzer KL
Am J Ophthalmol; 2000 Dec; 130(6):717-23. PubMed ID: 11124289
[TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy of olopatadine 0.1% ophthalmic solution versus levocabastine 0.05% ophthalmic suspension using the conjunctival allergen challenge model.
Abelson MB; Greiner JV
Curr Med Res Opin; 2004 Dec; 20(12):1953-8. PubMed ID: 15701212
[TBL] [Abstract][Full Text] [Related]
11. A comparison of topical mequitazine and disodium cromoglycate in allergic conjunctivitis induced by a specific conjunctival provocation test.
Dupin O; Trinquand C; Persi L; Bousquet J; Robert F; Arnaud B
Eur J Ophthalmol; 2000; 10(1):15-21. PubMed ID: 10744200
[TBL] [Abstract][Full Text] [Related]
12. Levocabastine: a new topical approach for the treatment of paediatric allergic rhinoconjunctivitis.
Janssens MM
Rhinol Suppl; 1992 Sep; 13():39-49. PubMed ID: 1358140
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of three antiallergic eyedrops in a specific conjunctival provocation test: mequitazine, levocabastine and dexamethasone].
Richard C; Bibas P; Lablache-Combier M; Allaire C
J Fr Ophtalmol; 2005 Mar; 28(3):244-50. PubMed ID: 15883488
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of 0.05% levocabastine versus 4% sodium cromolyn in the allergen challenge model.
Abelson MB; George MA; Smith LM
Ophthalmology; 1995 Feb; 102(2):310-6. PubMed ID: 7862419
[TBL] [Abstract][Full Text] [Related]
15. Levocabastine eye drops versus sodium cromoglycate in seasonal allergic conjunctivitis.
Wihl JA; Rudblad S; Kjellén H; Blychert LA
Clin Exp Allergy; 1991 May; 21 Suppl 2():37-8. PubMed ID: 1680537
[No Abstract] [Full Text] [Related]
16. Effect of a new selective H1 receptor antagonist (levocabastine) in a nasal and conjunctival provocation test.
Pécoud A; Zuber P; Kolly M
Int Arch Allergy Appl Immunol; 1987; 82(3-4):541-3. PubMed ID: 2883132
[TBL] [Abstract][Full Text] [Related]
17. New trends in the treatment of allergic conjunctivitis.
Parys W; Blockhuys S; Janssens M
Doc Ophthalmol; 1992; 82(4):353-60. PubMed ID: 1363981
[TBL] [Abstract][Full Text] [Related]
18. Effect of levocabastine, a new H1 antagonist, in a conjunctival provocation test with allergens.
Zuber P; Pécoud A
J Allergy Clin Immunol; 1988 Oct; 82(4):590-4. PubMed ID: 2902114
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of levocabastine in conjunctival provocation studies.
Janssens M
Doc Ophthalmol; 1992; 82(4):341-51. PubMed ID: 1363980
[TBL] [Abstract][Full Text] [Related]
20. Levocabastine eye drops: a new approach for the treatment of acute allergic conjunctivitis.
Abelson MB; Weintraub D
Eur J Ophthalmol; 1994; 4(2):91-101. PubMed ID: 7950341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
